Drug intelligence / Profile preview

hydrocortisone + neomycin sulfate + bacitracin zinc + polymyxin b sulfate

Development stage
Approved
Lead developer
Bausch + Lomb
Modality
Small Molecules, Peptides
Administration
Ophthalmic
01

Overview

**Hydrocortisone + neomycin sulfate + bacitracin zinc + polymyxin B sulfate** is a sterile prescription ophthalmic ointment combining a glucocorticoid anti-inflammatory agent with three topical antibacterial agents. Hydrocortisone activates the glucocorticoid receptor to suppress ocular inflammation; neomycin inhibits bacterial protein synthesis through the 30S ribosomal subunit; bacitracin disrupts bacterial cell-wall precursor recycling; and polymyxin B binds lipopolysaccharide and disrupts Gram-negative bacterial membranes. It is indicated for steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment when bacterial infection is present or a meaningful infection risk exists, including chronic anterior uveitis and corneal injury from chemical, thermal, or radiation burns or foreign bodies. The combination is contraindicated in most viral corneal or conjunctival diseases, mycobacterial ocular infection, and fungal ocular disease. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=3b00eb5c-dd98-467e-a883-04c37a8ecc42))

Brand names
Cortisporin Ophthalmic OintmentNeo-Poly-Bac HydroTriple Antibiotic HC
Other names
neomycin sulfate + polymyxin b sulfate + bacitracin zinc + hydrocortisone ophthalmic ointmentneomycin and polymyxin b sulfates + bacitracin zinc + hydrocortisone ophthalmic ointment
02

Targets

Bacterial RibosomeGR (Glucocorticoid receptor)LPS (Lipopolysaccharide (LPS) and associated phospholipids)C55-PP (Undecaprenyl pyrophosphate)

Beyond the preview

Go deeper on hydrocortisone + neomycin sulfate + bacitracin zinc + polymyxin b sulfate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydrocortisone + neomycin sulfate + bacitracin zinc + polymyxin b sulfate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call